American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Authors

Adam Cuker, University of Pennsylvania
Kristen M. Sanfilippo, Washington University School of Medicine in St. Louis
et al.

Journal

Blood Advances

Publication Date

2021

Volume

5

Issue

3

First Page

872

Last Page

888

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2020003763

Rights and Permissions

Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, Jennifer Davila, Maria T. DeSancho, David Diuguid, Daniel O. Griffin, Susan R. Kahn, Frederikus A. Klok, Alfred Ian Lee, Ignacio Neumann, Ashok Pai, Menaka Pai, Marc Righini, Kristen M. Sanfilippo, Deborah Siegal, Mike Skara, Kamshad Touri, Elie A. Akl, Imad Bou Akl, Mary Boulos, Romina Brignardello-Petersen, Rana Charide, Matthew Chan, Karin Dearness, Andrea J. Darzi, Philipp Kolb, Luis E. Colunga-Lozano, Razan Mansour, Gian Paolo Morgano, Rami Z. Morsi, Atefeh Noori, Thomas Piggott, Yuan Qiu, Yetiani Roldan, Finn Schünemann, Adrienne Stevens, Karla Solo, Matthew Ventresca, Wojtek Wiercioch, Reem A. Mustafa, Holger J. Schünemann; American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv 2021; 5 (3): 872–888. doi: https://doi.org/10.1182/bloodadvances.2020003763

Recommended Citation

Cuker, Adam; Sanfilippo, Kristen M.; and al., et, "American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19." Blood Advances. 5, 3. 872 - 888. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10126